Current role
Samuel Whiting
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Samuel Whiting
The proxy statement of Tempest Therapeutics, Inc. reports total compensation of $1,062,587 for Samuel Whiting in fiscal 2024, including a base salary of $481,749. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tempest Therapeutics, Inc. (TPST)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tempest Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Julia C. Owens CEO, Chairman
- Louis J. Arcudi III CEO, CFO, Board Member
- Matt Angel CEO, Board Member
- Matt Angel, Ph.D. CEO, Board Member
- Stephen R. Brady CEO
- Mike Raab Chairman, Board Member
- Stephen Brady Chairman
- Constance Ames CFO
- Jennifer Minai-Azary CFO
- Justin Trojanowski CFO, Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Tempest Therapeutics, Inc. (TPST) | Chief Medical Officer | $481,749 | $1,062,587 |
| 2023 | Tempest Therapeutics, Inc. (TPST) | Chief Medical Officer | $454,480 | $3,384,949 |
| 2022 | Tempest Therapeutics, Inc. (TPST) | Chief Medical Officer | $437,000 | $833,398 |
| 2021 | Tempest Therapeutics, Inc. (TPST) | Chief Medical Officer | $400,000 | $836,737 |
Recent activity
No call appearances or filed executive changes recorded yet.